PNC Financial Services Group
APTO

PNC Financial Services Group’s Aptose Biosciences, Inc. APTO Stock Holding History

PNC Financial Services Group’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7
Closed -$7K – 4682
2021
Q3 		$7K Hold
7
– – ﹤0.01% 3856
2021
Q2 		$10K Hold
7
– – ﹤0.01% 3718
2021
Q1 		$18K Hold
7
– – ﹤0.01% 3457
2020
Q4 		$13K Hold
7
– – ﹤0.01% 3502
2020
Q3 		$18K Hold
7
– – ﹤0.01% 3294
2020
Q2 		$19K Hold
7
– – ﹤0.01% 3238
2020
Q1 		$18K Buy
+7
New +$20.9K ﹤0.01% 3184

Other funds holding APTO

DRW Securities
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

PNC Financial Services Group's APTO Position: Q4 2021 in Review

PNC Financial Services Group sold out of Aptose Biosciences, Inc. (APTO) in Q4 2021, closing a stake of 7 shares — an estimated $7K sold.

PNC Financial Services Group first reported a position in APTO in Q1 2020 and held it in 7 quarters. The position peaked at $19K in Q2 2020. 58 funds tracked by Wall St. Rank hold APTO as of Q4 2021.

  • PNC Financial Services Group reported no remaining Aptose Biosciences, Inc. position as of Q4 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 7 Aptose Biosciences, Inc. shares in Q4 2021, an estimated $7K.
  • PNC Financial Services Group first reported a position in Aptose Biosciences, Inc. in Q1 2020 and held it in 7 quarters.
  • PNC Financial Services Group's Aptose Biosciences, Inc. position peaked at $19K in Q2 2020.
  • 58 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2021.

Based on PNC Financial Services Group's 13F filing for Q4 2021, filed 11 Feb 2022.